RECRUITING

Moms Managing Attention-Deficit/Hyperactivity Disorder (ADHD) Study

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study will develop and test a behavioral program for pregnant individuals with Attention-Deficit/Hyperactivity Disorder (ADHD). This behavioral program will include skills for managing ADHD and related symptoms during pregnancy and after delivery and will be taught by a behavioral therapist in OB care settings.

Official Title

Supporting Expectant Mothers with ADHD Through the Transition to Parenthood

Quick Facts

Study Start:2025-01-19

Study Completion:2025-12-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06540547

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 55 Years

Sexes Eligible for Study:FEMALE

Accepts Healthy Volunteers:No

Standard Ages:ADULT

Inclusion Criteria	Exclusion Criteria
* (1) meet full DSM-5 criteria for ADHD * (2) are between 20- and 32-weeks of gestation * (3) speak English * (4) will deliver at the University of Pittsburgh Medical Center (UPMC) Magee Women's Hospital (MWH)	* (1) active substance use disorder * (2) intellectual disability * (3) other severe mental illness, including bipolar disorder, psychosis, and major depressive disorder with suicidal ideation or requiring higher level of care (inpatient or partial/intensive outpatient) * (4) high risk pregnancies requiring transfer of care to Maternal-Fetal Medicine (e.g., maternal cancer, multiples, placenta accreta) and/or fetus known to have a severe congenital condition.

Inclusion Criteria

Exclusion Criteria

* (1) meet full DSM-5 criteria for ADHD
* (2) are between 20- and 32-weeks of gestation
* (3) speak English
* (4) will deliver at the University of Pittsburgh Medical Center (UPMC) Magee Women's Hospital (MWH)

* (1) active substance use disorder
* (2) intellectual disability
* (3) other severe mental illness, including bipolar disorder, psychosis, and major depressive disorder with suicidal ideation or requiring higher level of care (inpatient or partial/intensive outpatient)
* (4) high risk pregnancies requiring transfer of care to Maternal-Fetal Medicine (e.g., maternal cancer, multiples, placenta accreta) and/or fetus known to have a severe congenital condition.

Contacts and Locations

Study Contact

Heather M Joseph, DO

CONTACT

4122465339

liebherrh@upmc.edu

Michelle Wilson

CONTACT

412-420-8309

wilsonm13@upmc.edu

Principal Investigator

Heather M Joseph, DO

PRINCIPAL_INVESTIGATOR

University of Pittsburgh

Study Locations (Sites)

UPMC Magee Women's Hospital

Pittsburgh, Pennsylvania, 15213

United States

Collaborators and Investigators

Sponsor: University of Pittsburgh

Heather M Joseph, DO, PRINCIPAL_INVESTIGATOR, University of Pittsburgh

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-19

Study Completion Date2025-12-31

Study Record Updates

Study Start Date2025-01-19

Study Completion Date2025-12-31

Terms related to this study

Additional Relevant MeSH Terms

ADHD
Parenting